Log in to save to my catalogue

circMAN1A2 could serve as a novel serum biomarker for malignant tumors

circMAN1A2 could serve as a novel serum biomarker for malignant tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609809

circMAN1A2 could serve as a novel serum biomarker for malignant tumors

About this item

Full title

circMAN1A2 could serve as a novel serum biomarker for malignant tumors

Publisher

England: John Wiley and Sons Inc

Journal title

Cancer science, 2019-07, Vol.110 (7), p.2180-2188

Language

English

Formats

Publication information

Publisher

England: John Wiley and Sons Inc

More information

Scope and Contents

Contents

Novel diagnostic and prognostic biomarkers of cancers are needed to improve precision medicine. Circular RNAs act as important regulators in cancers at the transcriptional and posttranscriptional levels. The circular RNA circMAN1A2 is highly expressed in nasopharyngeal carcinoma according to our previous RNA sequencing data; however, the expression...

Alternative Titles

Full title

circMAN1A2 could serve as a novel serum biomarker for malignant tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609809

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609809

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.14034

How to access this item